Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spineart is a global leader in spine surgery innovation with a broad commercial portfolio of patented, clinically validated solutions including minimally invasive surgical devices, motion preservation technologies, 3D printed implants using Ti-LIFE technology, and streamlined instrumentation. The company is actively conducting pivotal clinical trials for its BAGUERA C cervical disc prosthesis in the United States and has recently launched new products such as SCARLET AC-Ti secured anterior cervical cage following FDA clearance. Clinical results from interim analyses are promising for multi-level symptomatic cervical disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spineart.